Optiprost Mini Eye Drop contains Bimatoprost 0.01% w/v, a prostaglandin analog used to lower elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension. Its low-strength formulation ensures effective pressure control with improved tolerability.
The eye drop works by increasing the outflow of aqueous humor, helping to maintain healthy eye pressure levels and protect the optic nerve, supporting long-term visual health.
From a franchise perspective, Optiprost Mini Eye Drop is a high-demand anti-glaucoma ophthalmic product, widely prescribed in eye hospitals, ophthalmology clinics, and specialty centers, ensuring consistent prescriptions and repeat sales.
Adding Optiprost Mini Eye Drop to your portfolio strengthens the ophthalmic anti-glaucoma segment, offering long-term growth, strong prescriber trust, and enhanced portfolio credibility for PCD pharma franchise partners.